Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.
2.

Potential prognostic tumor biomarkers in triple-negative breast carcinoma.

Peng Y.

Beijing Da Xue Xue Bao. 2012 Oct 18;44(5):666-72. Review.

3.

Triple-negative breast cancer: role of the androgen receptor.

Gucalp A, Traina TA.

Cancer J. 2010 Jan-Feb;16(1):62-5. doi: 10.1097/PPO.0b013e3181ce4ae1. Review. Erratum in: Cancer J. 2010 Nov-Dec;16(6):643.

PMID:
20164692
4.

Triple-negative breast cancer: an unmet medical need.

Hudis CA, Gianni L.

Oncologist. 2011;16 Suppl 1:1-11. doi: 10.1634/theoncologist.2011-S1-01. Review.

5.

The role of the androgen receptor in triple-negative breast cancer.

Shah PD, Gucalp A, Traina TA.

Womens Health (Lond). 2013 Jul;9(4):351-60. doi: 10.2217/whe.13.33. Review.

PMID:
23826776
6.

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, Seruga B, Tannock IF, Ocana A, Amir E.

J Natl Cancer Inst. 2014 Jan;106(1):djt319. doi: 10.1093/jnci/djt319. Epub 2013 Nov 22. Review.

7.

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.

Nahleh Z.

Future Oncol. 2008 Feb;4(1):15-21. doi: 10.2217/14796694.4.1.15. Review.

PMID:
18240997
8.

[Endocrinology of breast cancer as a heterogeneous disease: a decade after the millennium].

Bershteĭn LM.

Vopr Onkol. 2013;59(3):292-8. Review. Russian. No abstract available.

PMID:
23909028
9.

[Gene expression analysis and its clinical use in breast tumors].

Semiglazov VF, Semiglazov VV, Moiseenko FV, Bogdanov AA, Boĭtsov VV, Viaz'min SV, Gorab DN, Chubenko VA, Brezhnev NV, Luk'ianchikova VS, Dubina MV.

Vopr Onkol. 2013;59(1):25-9. Review. Russian. No abstract available.

PMID:
23805447
10.

Triple-negative breast cancer.

Chacón RD, Costanzo MV.

Breast Cancer Res. 2010;12 Suppl 2:S3. doi: 10.1186/bcr2574. Epub 2010 Oct 22. Review.

11.

A targetable androgen receptor-positive breast cancer subtype hidden among the triple-negative cancers.

Safarpour D, Tavassoli FA.

Arch Pathol Lab Med. 2015 May;139(5):612-7. doi: 10.5858/arpa.2014-0122-RA. Epub 2014 Oct 13. Review.

PMID:
25310144
12.

Breast cancer - one term, many entities?

Bertos NR, Park M.

J Clin Invest. 2011 Oct;121(10):3789-96. doi: 10.1172/JCI57100. Epub 2011 Oct 3. Review.

13.

Androgen receptor in triple negative breast cancer.

McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H.

J Steroid Biochem Mol Biol. 2013 Jan;133:66-76. doi: 10.1016/j.jsbmb.2012.08.007. Epub 2012 Sep 5. Review.

PMID:
22982153
Items per page

Supplemental Content

Write to the Help Desk